Marketing-authorisation holder · Canada
Orimed Pharma Inc
14 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
14 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BALANSYA2 mg / ml · Solution | Escitalopram | Canada | Marketed | 2026 |
| CACITRIX2 % / w/w + 16 % / w/w · Ointment | Lidocaine, Zinc oxide | Canada | Authorised | |
| CORNEO HYPROMELLOSE0.3 % · Solution | Hypromellose | Canada | Not marketed | 2015 |
| FLEXERIL10 mg · Tablet | Cyclobenzaprine | Canada | Not marketed | 2020 |
| FOLVITE5 mg · Tablet | Folic acid | Canada | Authorised | |
| LATANEO PF50 mcg / ml · Solution | Latanoprost | Canada | Authorised | |
| LUXA-D5000 unit · Capsule | Vitamin d | Canada | Marketed | 2015 |
| LUXA-D50000 unit · Capsule | Vitamin d | Canada | Not marketed | 2015 |
| LUXA-D25000 unit · Capsule | Vitamin d | Canada | Marketed | 2015 |
| LUXA-D2000 unit · Capsule | Vitamin d | Canada | Marketed | 2015 |
| LUXA-D10000 unit · Capsule | Vitamin d | Canada | Marketed | 2015 |
| SOLUFY1 mg / ml · Solution | Aripiprazole | Canada | Marketed | 2025 |
| VIDEXTRA10000 unit · Tablet | Vitamin d | Canada | Not marketed | 2014 |
| VITAMIN D3-SOFTGEL CAPSULES100000 unit · Capsule | Vitamin d | Canada | Authorised |